Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Buy
12,810
+59
+0.5% +$1.54K 0.13% 157
2026
Q1
$358K Buy
12,751
+889
+7% +$23.7K 0.18% 121
2025
Q4
$295K Buy
11,862
+1,679
+16% +$42.3K 0.15% 129
2025
Q3
$259K Buy
10,183
+5,541
+119% +$137K 0.1% 175
2025
Q2
$113K Sell
4,642
-4,099
-47% -$95.6K 0.06% 244
2025
Q1
$222K Buy
8,741
+63
+0.7% +$1.65K 0.09% 215
2024
Q4
$230K Buy
+8,678
New +$235K 0.11% 184

Other funds holding PFE

AmeriFlex Group's PFE Position: Q2 2026 in Review

AmeriFlex Group increased its Pfizer (PFE) stake by 0.46% in Q2 2026, buying an estimated $1.54K and bringing the position to 12,810 shares worth $308K. The position accounts for 0.13% of the portfolio, ranked #157.

AmeriFlex Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $358K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • AmeriFlex Group held 12,810 shares of Pfizer worth $308K as of Q2 2026.
  • AmeriFlex Group bought 59 Pfizer shares in Q2 2026, an estimated $1.54K.
  • Pfizer made up 0.13% of AmeriFlex Group's portfolio in Q2 2026, its #157 holding.
  • AmeriFlex Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Pfizer position peaked at $358K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.